18F-THK5351 Positron Emission Tomography Imaging in Neurodegenerative Tauopathies

18F-THK5351 Positron Emission Tomography Imaging in Neurodegenerative Tauopathies

Introduction: We aimed to determine whether in vivo tau deposits and monoamine oxidase B (MAO-B) detection using 18F-THK5351 positron emission tomography (PET) can assist in the differential distribution in patients with corticobasal syndrome (CBS), progressive supranuclear palsy (PSP), and Alzheime...

Full description

Bibliographic Details
Main Authors:	Michinori Ezura, Akio Kikuchi, Nobuyuki Okamura, Aiko Ishiki, Takafumi Hasegawa, Ryuichi Harada, Shoichi Watanuki, Yoshihito Funaki, Kotaro Hiraoka, Toru Baba, Naoto Sugeno, Shun Yoshida, Junpei Kobayashi, Michiko Kobayashi, Ohito Tano, Shun Ishiyama, Takaaki Nakamura, Ichiro Nakashima, Shunji Mugikura, Ren Iwata, Yasuyuki Taki, Katsutoshi Furukawa, Hiroyuki Arai, Shozo Furumoto, Manabu Tashiro, Kazuhiko Yanai, Yukitsuka Kudo, Atsushi Takeda, Masashi Aoki
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2021-11-01
Series:	Frontiers in Aging Neuroscience
Subjects:	tau deposits 18F-THK5351 positron emission tomography (PET) corticobasal syndrome (CBS) Alzheimer’s disease (AD) tauopathy
Online Access:	https://www.frontiersin.org/articles/10.3389/fnagi.2021.761010/full

Similar Items

Neuroimaging-pathological correlations of [18F]THK5351 PET in progressive supranuclear palsy
by: Aiko Ishiki, et al.
Published: (2018-06-01)

[18F]-THK5351 PET Correlates with Topology and Symptom Severity in Progressive Supranuclear Palsy
by: Matthias Brendel, et al.
Published: (2018-01-01)

[18F]THK-5351 PET imaging in early-stage semantic variant primary progressive aphasia: a report of two cases and a literature review
by: Ryota Kobayashi, et al.
Published: (2018-08-01)

Comparative binding properties of the tau PET tracers THK5117, THK5351, PBB3, and T807 in postmortem Alzheimer brains
by: Laetitia Lemoine, et al.
Published: (2017-12-01)

Regional cerebral THK5351 accumulations correlate with neuropsychological test scores in Alzheimer continuum
by: SungWoon Im, et al.
Published: (2023-01-01)

Longitudinal Assessment of Tau-Associated Pathology by <sup>18</sup>F-THK5351 PET Imaging: A Histological, Biochemical, and Behavioral Study
by: Ines Moreno-Gonzalez, et al.
Published: (2021-10-01)

Monoamine oxidase B inhibitor, selegiline, reduces 18F-THK5351 uptake in the human brain
by: Kok Pin Ng, et al.
Published: (2017-03-01)

THK5351 and flortaucipir PET with pathological correlation in a Creutzfeldt-Jakob disease patient: a case report
by: Hee Jin Kim, et al.
Published: (2019-08-01)

Temporal and spatial changes in reactive astrogliosis examined by 18F-THK5351 positron emission tomography in a patient with severe traumatic brain injury
by: Tetsuhiro Hatakeyama, et al.
Published: (2021-12-01)

Error propagation analysis of seven partial volume correction algorithms for [18F]THK-5351 brain PET imaging
by: Senri Oyama, et al.
Published: (2020-09-01)

Relationship between the temporal course of astrogliosis and symptom improvement in cerebral infarction: report of a case monitored using 18F-THK5351 positron emission tomography
by: Kenji Ishibashi, et al.
Published: (2020-07-01)

Involvement of the Precuneus/Posterior Cingulate Cortex Is Significant for the Development of Alzheimer’s Disease: A PET (THK5351, PiB) and Resting fMRI Study
by: Takamasa Yokoi, et al.
Published: (2018-10-01)

PET Imaging of Astrogliosis and Tau Facilitates Diagnosis of Parkinsonian Syndromes
by: Sonja Schönecker, et al.
Published: (2019-09-01)

MicroPET Imaging Assessment of Brain Tau and Amyloid Deposition in 6 × Tg Alzheimer’s Disease Model Mice
by: ShinWoo Kang, et al.
Published: (2022-05-01)

Tau PET With 18F-THK-5351 Taiwan Patients With Familial Alzheimer's Disease With the APP p.D678H Mutation
by: Chin-Chang Huang, et al.
Published: (2019-05-01)

<sup>18</sup>F–THK–5351, Fluorodeoxyglucose, and Florbetaben PET Images in Atypical Alzheimer’s Disease: A Pictorial Insight into Disease Pathophysiology
by: Sohee Park, et al.
Published: (2021-04-01)

Single-word comprehension deficits in the nonfluent variant of primary progressive aphasia
by: Jolien Schaeverbeke, et al.
Published: (2018-07-01)

Lung carcinoma–associated cognitive impairment in a patient with Alzheimer’s disease pathology: A case report
by: Kiyoto Takigawa, et al.
Published: (2021-07-01)

In vivo imaging of tau deposition in Alzheimer’s disease using both [18F]-THK5317 and [18F]-S16: A pilot human study
by: Liping Fu, et al.
Published: (2022-08-01)

Author Correction: 18F-THK5351 PET imaging in patients with progressive supranuclear palsy: associations with core domains and diagnostic certainty
by: Jung-Lung Hsu, et al.
Published: (2021-02-01)

Longitudinal study of primary progressive aphasia in a patient with pathologically diagnosed Alzheimer’s disease: a case report
by: Masahiko Takaya, et al.
Published: (2021-05-01)

Multi-organ comparison and quantification parameters of [18F]THK-5317 uptake in preclinical mouse models of tau pathology
by: Thomas Wanek, et al.
Published: (2023-12-01)

GDSS Development of Bali Tourism Destinations With AHP and Borda Algorithms Based on Tri Hita Karana
by: Putu Sugiartawan, et al.
Published: (2022-07-01)

Pharmacological interventions in corticobasal degeneration: a review
by: Leonardo Caixeta, et al.
Published: (2020-09-01)

Corticobasal syndrome: A diagnostic conundrum
by: Jacy Bezerra Parmera, et al.

The Significance of Vascular Pathogenesis in the Examination of Corticobasal Syndrome
by: Anna Dunalska, et al.
Published: (2021-05-01)

High sensitivity of asymmetric 18F-THK5351 PET abnormality in patients with corticobasal syndrome
by: Masanori Kurihara, et al.
Published: (2023-07-01)

Early brainstem [18F]THK5351 uptake is linked to cortical hyperexcitability in healthy aging
by: Maxime Van Egroo, et al.
Published: (2021-01-01)

Unravelling Genetic Factors Underlying Corticobasal Syndrome: A Systematic Review
by: Federica Arienti, et al.
Published: (2021-01-01)

Corticobasal degeneration and corticobasal syndrome: A review
by: Vasilios C. Constantinides, et al.
Published: (2019-01-01)

18F-THK 5351 and 11C-PiB PET of the Thai normal brain template
by: Chanisa Chotipanich, et al.
Published: (2021-01-01)

The Discourse Profile in Corticobasal Syndrome: A Comprehensive Clinical and Biomarker Approach
by: Isabel Junqueira de Almeida, et al.
Published: (2022-12-01)

Combination of automated brain volumetry on MRI and quantitative tau deposition on THK-5351 PET to support diagnosis of Alzheimer’s disease
by: Minjae Kim, et al.
Published: (2021-05-01)

Suppression of Myoclonus in Corticobasal Degeneration by Levetiracetam
by: Jae Wook Cho, et al.
Published: (2014-04-01)

Cognitive dysfunction in corticobasal degeneration
by: Laís Machado de Oliveira, et al.

Large inter- and intra-case variability of first generation tau PET ligand binding in neurodegenerative dementias
by: Melissa C. Wren, et al.
Published: (2018-05-01)

Corticobasal syndrome as a phenotype of various neurodegenerative disorders: a case series
by: Yuliya A. Shpilyukova, et al.
Published: (2022-01-01)

Case Report: Concomitant Alzheimer's and Lewy-Related Pathology Extending the Spectrum of Underlying Pathologies of Corticobasal Syndrome
by: Michaela Kaiserová, et al.
Published: (2021-11-01)

Gray matter structural networks related to 18F-THK5351 retention in cognitively normal older adults and Alzheimer's disease patients
by: Yoko Shigemoto, et al.
Published: (2021-03-01)

Dampak Penerapan Kultur Lokal Tri Hita Karana terhadap Orientasi Kewirausahaan dan Orientasi Pasar
by: I Gede Riana
Published: (2011-01-01)